about
Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics.Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination.Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy.Harnessing human plasmacytoid dendritic cells as professional APCs.Deciphering the message broadcast by tumor-infiltrating dendritic cells.Tumoricidal activity of human dendritic cells.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function.CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.Naturally circulating dendritic cells to vaccinate cancer patients.Selective Expression of the MAPK Phosphatase Dusp9/MKP-4 in Mouse Plasmacytoid Dendritic Cells and Regulation of IFN-β Production.Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.Dendritic Cells as Vaccines: Key Regulators of Tolerance and ImmunityThe chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?CD56 marks human dendritic cell subsets with cytotoxic potential.IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.An electro-coalescence chip for effective emulsion breaking in droplet microfluidics.Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma PatientsPolymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell ResponsesTargeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN SecretionThe C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cellsDEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cellsHuman Plasmacytoid Dendritic Cells Phagocytose, Process, and Present Exogenous Particulate AntigenSingle-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cellsAbstract IA29: Towards synthetic immune cells for cancer immunotherapyCirculating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosisEffective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic CellsCross-talk between human dendritic cell subsets influences expression of RNA sensors and inhibits picornavirus infection
P50
Q34382174-4FFA0B82-4BDA-4F4B-9B2E-A3A28A6E9FC4Q34428078-B2650ACA-57BE-4E77-8C4C-65FF08B98EDAQ34532389-6E345691-55A0-4F38-8DDC-F08FD6622894Q36597497-D1360ECC-3F70-4F29-8BA4-5D740641F1D8Q37702840-D1974185-F9F6-4A78-9E70-EAF133D0C4F8Q37980404-6F94AB85-40AE-49A8-BE39-45F781C65B5EQ38026363-90B4B3B7-6DC4-4498-988B-D95B4C320A3CQ38164916-B0A75843-B53D-45A3-B7B4-95D002EDDD69Q38206571-463F6BA9-A996-49AF-8D49-CE85A57170E9Q38564323-6CB6E83A-A16F-4B78-8680-11F9420F7925Q38576179-45FCDABC-947E-41FC-8AE0-755B85590B67Q39281392-9BCC0E91-B3BD-4DE4-895D-C62D28644009Q39392060-C43D9211-6772-4A61-B789-5B6CD14928F7Q39448429-ADC3999D-6489-4434-A27E-A84C0311F6B3Q40155520-0377C5AE-3AC2-4843-910E-34154C557B69Q40930007-5C452CB9-7F56-4AA4-B85B-245ADD9CDE54Q41110211-01B2D64C-B14A-49A2-BB6D-B83BE2FA4382Q41835523-49508DAB-A621-449F-8E0C-D2AB470F2EFAQ41933827-6336F1C3-54E2-4139-BE19-F5B507EE968DQ41949368-51F3D77C-7A19-4E83-BD10-74629E444042Q42017071-C30CC6A4-1B79-4274-AB7E-20DB68A3CD7BQ42245307-FD90D5CB-D5D2-449D-A038-2143FC57992EQ42269630-B7D77BDB-542F-4F9B-9BEC-CD2ED5759BE6Q45370179-079078AF-75FE-47FF-BA51-91C45F447EDDQ46876439-A7F71E42-B601-494E-B53F-57FDDC5C0A48Q48356056-DF6C4714-7089-4C73-82D7-F4262E7C4789Q48657577-B67A9A76-7B20-4193-AA0F-38E0E62BABD5Q51514713-2C92E9FB-06A5-448F-9443-7A643209BE33Q53901177-BD4D7011-FA60-4208-840C-E957A7872945Q57779512-03BE48FF-E013-429F-AF17-FEBD30D7D87DQ58490532-93FA92DD-8FF3-4945-841D-12B11A854D86Q58619877-B71E7360-E30C-45C0-8721-8DAAAA7F780DQ58619899-4303E10F-3924-4150-9C30-5E07446E9C76Q58619914-A99F10A1-2AFC-4B7A-A1EA-AA78FE14A239Q58619944-1B412B9D-17CA-440B-909A-FBA1CDC12730Q58765498-2A4A9664-5258-4CD8-8FAE-FEC94E75E9B1Q63972778-2151CA9E-8545-4643-AC51-C7CD06FBBFE5Q64166969-15FBE948-DF60-4B8B-A895-C1688D3C14F4Q64166970-07C48C26-40CD-4D94-A8C6-2A948A1F4B54Q84019735-31754E40-5572-460E-9206-0A4AB7A446B2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Jurjen Tel
@ast
Jurjen Tel
@en
Jurjen Tel
@es
Jurjen Tel
@nl
Jurjen Tel
@sl
type
label
Jurjen Tel
@ast
Jurjen Tel
@en
Jurjen Tel
@es
Jurjen Tel
@nl
Jurjen Tel
@sl
prefLabel
Jurjen Tel
@ast
Jurjen Tel
@en
Jurjen Tel
@es
Jurjen Tel
@nl
Jurjen Tel
@sl
P1006
P214
P1006
P1053
A-2712-2016
P106
P21
P213
0000 0004 1946 3662
P214
P31
P3829
P496
0000-0002-7213-3422
P7859
viaf-283294764